Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Dude51on May 01, 2022 11:37am
263 Views
Post# 34645922

Clas is just a scam, ask Drew

Clas is just a scam, ask DrewI jumped at 32 cents because of a poster on Drew's site basically calling these guys out. This fellow basically said you can be charged for fraud and making bogus claims. So when I mentioned it on Drew's site or here on Stockhouse that I had bailed on CLAS he deleted me as a patron of his site and continued with the scam and bogus nothing berger interviews with Rob and Salzman. They can't even do their accounting in a timely manner that should tell you something. I was wanting to come back because I was hoping I was wrong but doesn't look like I was. Was in it for couple of years believe the BS.

I jumped into THRM  and am still in THRM and it's real close to FDA imo. Watch out for THRM though it's under heavy attack from shorters, its constant. But they THRM have gotten institutional investors to invest something that has not happened with CLAS from my readings.  Soon as that happened though the stock tanked 50% after the 6 Mill PP. Who would invest 6 mill into a company then right after its drops 50% in value? Shorters, is just my guess.

This 6 mill that the company walked away with, aka the PP was just after they announced they had submitted all result to FDA for EUA. “Therma Bright Inc. has submitted its United States Food & Drug Administration's (FDA) Emergency Use Authorization (EUA) application for its smart-enabled AcuVid COVID-19 rapid antigen saliva test for point of care (POC).”

So when it tanked it caused a lot of people to sell. But what institutional investor “H.C. Wainwright & Co. is acting as the exclusive placement agent for the private placement.”  does this? Invests 6 mill then it drops 50%, so I bought more.  My average buy was 42 cents now 32 cents.

So were still alive and if you google how long it takes FDA on EUA applications of late you will find the answer is about 4 to 5 weeks on average.
It was 4 weeks April 29th, so this week? Remember the shortes are attacking constantly, but they might be a bit hesitant this week. GL, byte me Drew.
<< Previous
Bullboard Posts
Next >>